Periarthritic Shoulder/Adhesive capsulitis
Periarthritic Shoulder, often referred to as Adhesive capsulitis (AC), is characterized by initially painful and later progressively restricted active and passive glenohumeral (GH) joint range of motion with spontaneous complete or nearly complete recovery over a varied period of time.This inflammatory condition causes fibrosis of the GH joint capsule, is accompanied by gradually progressive stiffness and significant restriction of range of motion (typically external rotation).Risk Factors & Red Flags
- Diabetes mellitus (with a prevalence of up to 20%)
- Stroke
- Thyroid disorder
- Shoulder injury (direct impact, dislocation)
- Dupuytren’s disease
- Parkinson’s
- Complex regional pain syndrome
- Avascular necrosis (rare, but can occur)
- Tuberculosis
- Shortness of breath, severe cough, any compromises to the quality of the breath
- Metastatic disease
- Rheumatisms
- Multiple joint involvement
- Fever, chills, severe (inexplicable) pain
- History of cancer (to the individual, or family)
- Any suspicion of a systemic pathology or condition.
- Acute/freezing/painful phase: Gradual onset of shoulder pain at rest with sharp pain at extremes of motion, and pain at night with sleep interruption which may last anywhere from 2-9 months.
- Adhesive/frozen/stiffening phase: Pain starts to subside, with progressive loss of GH motion in the capsular pattern. Pain is apparent only at extremes of movement. This phase may occur at around 4 months and last for about 12 months.
- Resolution/thawing phase: Spontaneous, progressive improvement in functional range of motion which can last anywhere from 5 to 24 months. Despite this, some studies suggest that it’s a self-limiting condition, and may last up to three years. However other studies have shown that up to 40% of patients may have persistent symptoms and restriction of movement beyond three years. It is estimated that 15% may have persistent pain and long-term disability. Effective treatments that shorten the duration of the symptoms and disability will have a significant value in reducing morbidity.